HANNAH SCHAMBURG: Open Payments
NPI 1073169546 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 63 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $242 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $151 |
| Vanda Pharmaceuticals Inc. | 7 | $140 |
| Janssen Biotech, Inc. | 4 | $86 |
| Axsome Therapeutics, Inc. | 5 | $85 |
| ABBVIE INC. | 4 | $77 |
| Lundbeck LLC | 3 | $56 |
| Corcept Therapeutics | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Novo Nordisk Inc | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
Products named: CAPLYTA, HETLIOZ, TREMFYA, Auvelity, REXULTI, Korlym, VRAYLAR, FARXIGA.
Industry payments across IN — which companies pay providers there.
